Bank of Nova Scotia »

Eyepoint Pharmaceuticals shares owned by Bank of Nova Scotia

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Bank of Nova Scotia from 13F filings

Historical chart of Bank of Nova Scotia investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Bank of Nova Scotia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Bank of Nova Scotia

Quarter filed Position value Share count Share price at filing
2025-09-30 $158k 11k 14.24

More positions owned by Bank of Nova Scotia

NVIDIA Corporation (NVDA)
Apple (AAPL)
Key (KEY)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Cibc Cad (CM)
Broadcom (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Bank Of Montreal Cadcom (BMO)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Meta Platforms Cl A (META)

View all positions for Bank of Nova Scotia

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
Adage Capital Partners GP
BlackRock
Federated Investors
Franklin Resources
Vanguard Group
TCG Crossover Management
Citadel Advisors
Paradigm Biocapital Advisors
OrbiMed Advisors
Geode Capital Management
Goldman Sachs Group
State Street Corporation
Essex Woodlands Health Ventures

View all funds holding Eyepoint Pharmaceuticals